紧急治疗对于残疾人短暂性缺血发作和轻度中风的影响和住院费用(EXPRESS研究):一项基于人群的前瞻性序列比较研究
发布于:2009-02-12 08:54
Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison
紧急治疗对于残疾人短暂性缺血发作和轻度中风的影响和住院费用(EXPRESS研究):一项基于人群的前瞻性序列比较研究
背景
在治疗的有效性和价值中来减少长期二次预防中风风险过程,证据是有用的。
在长期二级预防中减少中风风险治疗的有效性和费用方面有很多证据。
但是,在短暂性缺血发作(TIA)或轻度中风的开始后,治疗和紧急评估的费用和结果的数据是比较少的。早期已经有的中风预防策略(EXPRESS)研究的使用表明紧急评估和治疗可使得再次中风的90天风险减少大约80%。我们现在报道EXPRESS介入后对于入院申请、费用和残疾的影响。
方法
EXPRESS研究是一个前瞻性基于人群的前(2002年4月1日至2004年9月30日,第一阶段)后(2004年10月1日至2007年3月31日,第二阶段)对比研究,该研究是关于早期评价和治疗TIA或轻度中风对于早期再发中风风险影响研究。此报道评估了与第一阶段相比第二阶段临床对于入院90天内、入院天数、住院费用和6个月新发的残疾(从之前的非残疾[modified Rankin scale score ≤2 points]到6个月后的残疾[modified Rankin scale score >2 points])或死亡的影响。为了评估这些结果的主要预测,采用了多变量回归分析。
结果
90天致命性或残疾性中风的风险在第二阶段中减少( 281例中有1 例对比310例中有16例,p=0.0005)。在第二阶段因再发中风入院对比第一阶段也较少(5比25,p=0.001),其总住院天数比第一组也更少(672 比1957天,p=0.017)。由于心血管原因入院住院天数在第二阶段中也更低(427比1365 天,p=0.016),总体上第二阶段每个患者节约624英镑(p=0.028)。多变量分析的结果表明第二阶段评价是一个减少残疾、住院时间和费用的独立预测。
解释
由专科医师门诊对患有TIA或轻度中风患者的紧急评估和治疗减少了随后的住院时间、紧急费用和6个月后残疾。
Source:www.thelancet.com
《医心评论》编辑:呼唤 翻译 毛新罡 校对
Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison
Background
Evidence is available on the effectiveness and costs of treatments to reduce stroke risk in long-term secondary prevention. However, there are few data on the costs and outcomes of urgent assessment and treatment after the onset of transient ischaemic attack (TIA) or minor stroke. The Early use of eXisting PREventive Strategies for Stroke (EXPRESS) study showed that urgent assessment and treatment reduced the 90-day risk of recurrent stroke by about 80%. We now report the effect of the EXPRESS intervention on admissions to hospital, costs, and disability.
Methods
EXPRESS was a prospective population-based before (phase 1: April 1, 2002, to Sept 30, 2004) versus after (phase 2: Oct 1, 2004, to March 31, 2007) study of the effect of early assessment and treatment of TIA or minor stroke on the risk of early recurrent stroke.
This report assesses the effect of the introduction of the phase 2 clinic on admissions to hospital within 90 days, hospital bed-days, hospital costs, and 6-month new disability (progression from no disability before event [modified Rankin scale score ≤2 points] to disability at 6 months [modified Rankin scale score >2 points]) or death, compared with the phase 1 clinic. To assess the main predictors of these outcomes, multivariate regression analyses were done.
Findings
The 90-day risk of fatal or disabling stroke was reduced in phase 2 (1 of 281 vs 16 of 310; p=0•0005). Hospital admissions for recurrent stroke were also lower in phase 2 than in phase 1 (5 vs 25; p=0•001), which reduced the overall number of hospital bed-days compared with phase 1 (672 vs 1957 days; p=0•017). Hospital bed-days for admissions to hospital due to vascular causes were also lower in phase 2 (427 vs 1365 days; p=0•016), which generated savings of £624 per patient referred to the phase 2 clinic (p=0•028). Results from the multivariate analyses showed that assessment in phase 2 was an independent predictor of reduced disability, days in hospital, and costs.
Interpretation
Urgent assessment and treatment of patients with TIA or minor stroke who were referred to a specialist outpatient clinic reduced subsequent hospital bed-days, acute costs, and 6-month disability.
Funding
UK Department of Health; UK Medical Research Council; Dunhill Medical Trust; Stroke Association; BUPA Foundation; National Institute for Health Research; Thames Valley Primary Care Research Partnership; Oxford Partnership Comprehensive Biomedical Research Centre.
来源: 医心网



京公网安备 11010102002968号